El nuevo informe de Informes de Expertos titulado ‘Mercado Latinoamericano de Inyectables Genéricos, Informe y Pronóstico 2022-2027′, ofrece un análisis profundo del mercado, evaluándolo por el área terapéutica, el tipo de contenedor, el canal de distribución, y regiones. El informe analiza los factores clave de éxito y las limitaciones, también rastrea las últimas tendencias en la industria y estudia su impacto en el mercado en general. Además, evalúa la dinámica del mercado, cubriendo los indicadores clave de demanda y precio, junto con un análisis FODA y el análisis basado en el modelo de cinco fuerzas de Porter.
The new report by Informes de Expertos titled, ‘Latin America Generic Injectables Market Report and Forecast 2022-2027’, gives an in-depth analysis of the market, assessing it based on therapeutic area, container, distribution channel, and key regions. The report analyses key success factors and constraints, tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-inyectables-genericos/solicitar-una-muestra
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): X%
The expansion of the pharmaceutical industry and an increasing prevalence of chronic and life-threatening diseases are instrumental in driving the growth of generic injectables in Latin America. As these injectables aid in alleviating pains and after-effects of chemotherapy, the demand for generic injectables proliferates owing to the increasing cases of cancer. A rising focus on biologics and targeted therapies and the patent expiry of a number of blockbuster drugs further promote market growth.
Read Full Report with Table of Contents – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-inyectables-genericos
Industry Definition and Major Segments
Generic injectables are bioequivalent of their brand-name injectable counterparts and act as an alternative to oral drugs. As they are similar in terms of dosage, active ingredients, potency and intended use to the original drugs, they are as safe and effective as innovator drugs. They require a high degree of care and diligence in their manufacture, storage and distribution; however, their R&D cycles are shorter and cheaper.
By therapeutic area, the market is segmented into:
- Oncology
- Anaesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
- others
Based on container type, the market has been evaluated and segmented into:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
- Others
By distribution channels, the industry can be further segmented into:
- Hospitals
- Retail Pharmacy
Key regions covered include:
- Brazil
- Argentina
- Mexico
- Chile
- Others
Market Trends
With the increasing incidences of cancer and other diseases, there is a growing necessity to use generic formulae to develop drugs that are affordable and of quality, which has contributed to the growth of generic injectables. Prevalence of lifestyle-based diseases such as diabetes and the growing geriatric population are also factors promoting the market growth. Moreover, demand for cost-effective biologics and government support for the production and distribution of generic injectables aid the market further.
The rise in mergers and acquisitions and technological advancements in drug delivery systems also positively impact the market. Increasing patent expirations and growth in demand for affordable medicines are expected to propel the generic injectables market further.
Key Industry Players
The major players in the industry are:
- Fresenius SE & Co. KGaA
- Hikma Pharmaceuticals PLC
- Sagent Pharmaceuticals, Inc.
- Sanofi
- Sandoz (Novartis)
- Others
This report covers their profiles and provides information on expansions, investments and mergers and acquisitions, among other latest industry developments.
About Us:
Informes de Expertos (https://informesdeexpertos.com), the Spanish variant of Expert Market Research, is a platform that offers market research and consultancy services to a broad clientele base across Spanish speaking countries. With our primary focus on the Latin America and Spain markets, our research experts provide relevant and actionable insights into the markets and track major trends, economic developments, and global trade data.
Also Visit – https://informesdeexpertos.blogspot.com/
Determined to bring client satisfaction, we make sure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and customized research reports cover a wide spectrum of industries ranging from pharmaceuticals and food and beverage to packaging, logistics, and transportation.
Media Contact
Company Name: Informes De Expertos
Contact Person: Chris Smiths, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1 (818) 319-4060
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.informesdeexpertos.com/
Related Reports
- Mercado Latinoamericano de Medicina Herbaria – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-medicina-herbaria
- Mercado Latinoamericano de Antibióticos Orales – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-antibioticos-orales
- Mercado Latinoamericano de Nanomedicina – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-nanomedicina
- Mercado Latinoamericano de Cápsulas Vacías – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-capsulas-vacias
- Mercado Latinoamericano de Alprazolam en Polvo – https://www.informesdeexpertos.com/informes/mercado-latinoamericano-de-alprazolam-en-polvo
We at Informes de Expertos always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
Several top players in the generic injectables market are focusing on mergers and acquisitions to consolidate their shares.
They are also making substantial investment in research and development activities with an aim to develop new products, in order to gain an edge over their competitors, notes Transparency Market Research (TMR).
Some of the companies holding leading positions in the market are Biocon Limited, Sanofi, Lupin Ltd., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Baxter, Novartis AG (Sandoz International GmbH), and Pfizer Inc.A growing number of producers of generic injectables are focusing on products that meet the highest standard of efficacy and safety as that of the originator products.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=42698The global generic injectables market is projected to expand rapidly from its worth of US$ 49.0 billion in 2016 to reach a worth of over US$ 150 billion by 2025.
This represents a robust CAGR of nearly 13.6% during the forecast period of 2017–2025.The various product types can be grouped into ampoules, vials, premixes, and prefilled syringes.
Of all the segments, the market for prefilled syringes is expected to rise at the most attractive CAGR during the assessment period.
The higher precision of dose, ease of self-administration, and reduced wastage of products are some of the compelling benefits accounting for their widespread acceptance.Regionally, Asia Pacific led the global market in 2016 with substantial uptake of generic injectables among patient populations.
The global generic injectables market is expected to exhibit a solid 13% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The global generic injectables market is mainly driven by the growing prevalence of noncommunicable diseases, which are mainly treated by injectables.
The increasing prevalence of flu and other seasonal maladies has been a major driver for the generic injectables market.
The growing effects of climate change are making seasonal maladies more severe, as more severe allergens and pathogens are being thrown up into the mix due to the shakeup caused by climate change.
The increasing prevalence of cancer, AIDS, and other noncontagious diseases is also likely to be a major driver for the global generic injectables market over the forecast period.Competitive Analysis:Leading players in the global generic injectables market include Novartis AG, Baxter, Fresenius SE & Co. KGaA, Mylan NV, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, Sanofi, Biocon, Reddy’s Laboratories, Aurobindo Pharma, Zydus Cadila, GSK plc, and AstraZeneca plc.
Generic injectables and biosimilar APIs will be the company’s main focus in the coming months.
Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Global Forecast Till 2027The global generic injectables market is expected to exhibit a solid 13% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The global generic injectables market is mainly driven by the growing prevalence of noncommunicable diseases, which are mainly treated by injectables.
The increasing prevalence of flu and other seasonal maladies has been a major driver for the generic injectables market.
The growing effects of climate change are making seasonal maladies more severe, as more severe allergens and pathogens are being thrown up into the mix due to the shakeup caused by climate change.
The increasing prevalence of cancer, AIDS, and other noncontagious diseases is also likely to be a major driver for the global generic injectables market over the forecast period.
The use of generic injectables for treating cancer, in particular, is growing and is likely to play a key role in the global generic injectables market’s growth in the coming years.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7512 Growing research and drug development initiatives from government as well as nongovernmental medical research institutions is also likely to be a major driver for the global generic injectables market over the forecast period.
